Maravai Lifesciences Holdings (MRVI) Debt Ratio (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Debt Ratio of 0.35 for Q1 2026, up 12.44% year-over-year from 0.31 in Q1 2025, and down 8.74% quarter-over-quarter from 0.38 in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Debt Ratio (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.35 for Q1 2026.
- In Q1 2026, Debt Ratio rose 12.44% year-over-year to 0.35; the TTM figure through Mar 2026 stood at 0.35 (up 12.44% YoY), while the FY2025 annual figure was 0.38, up 26.67% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.35, down from 0.38 in the prior quarter.
- The five-year high for Debt Ratio was 0.41 in Q3 2024, with the low at 0.23 in Q4 2022.
- The 5-year median for Debt Ratio is 0.33 (2025), against an average of 0.32.
- The sharpest annual moves came in 2023 and 2024: Debt Ratio plunged 32.4% in 2023, then soared 76.3% in 2024.
- Maravai Lifesciences Holdings' Debt Ratio stood at 0.23 in 2022, then surged by 54.06% to 0.36 in 2023, then fell by 16.05% to 0.3 in 2024, then advanced by 26.67% to 0.38 in 2025, then slipped by 8.74% to 0.35 in 2026.
- Business Quant data shows MRVI's Debt Ratio at 0.35 in Q1 2026, 0.38 in Q4 2025, and 0.34 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.25 |
| Mar 31, 2026 | 0.35 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.34 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.30 |
| Sep 30, 2024 | 0.41 |
| Jun 30, 2024 | 0.36 |
| Mar 31, 2024 | 0.36 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.23 |
| Mar 31, 2023 | 0.29 |
| Dec 31, 2022 | 0.23 |
| Sep 30, 2022 | 0.32 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.28 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.28 |